Table 2.
Gastrointestinal adverse reaction | Myelosuppression | |||||||
Study and year | Fever | Chills | Rash | Headache | Chemo/CIT | Control | Chemo/CIT | Control |
Chang et al 2013 | – | – | – | – | 48.5% | 54.5% | 24.2% | 39.4% |
Shu et al 2015 | 74.6% | – | – | Mild | – | – | – | – |
Wen et al 2015 | – | – | – | – | 82.9% | 80% | 78% | 80% |
Xi et al 2015 | 11.5% | – | – | – | – | – | – | – |
Yan et al 2015 | 8.8% | Mild | – | – | 55.9% | 73.5% | 11.8% | 44.1% |
Zhao et al 2015 | 64% | 20% | 10% | – | 62% | 88% | 52% | 74% |
Zhang et al 2016 | 65.6% | 3.1% | – | – | Mild | Mild | 1–2 degree | 1–2 degree |
CIK = cytokine-induced killer cell, CIT = chemotherapy-induced thrombocytopenia, DC/CIK = dendritic cell–cytokine-induced killer cell.